🔬
You have used your free lookups for today
Upgrade to BiotechSigns Pro for unlimited company access, full signal history, watchlist alerts, and 125+ PDUFA dates.
Upgrade to Pro →← Back to screener
← Back to Screener
S

SGI

Somnigroup International Inc.
RNA TherapyScore: 56/100📋 Full Profile
C
56

What is the current SGI catalyst setup?

SGI is tracked by BiotechSigns with a current catalyst score of 56/100 and grade C. The page summarizes 0 active signals, including 0 PDUFA, 0 insider buying, and 0 clinical trial signals, with data refreshed on 2026-06-03.

Analyst Summary
Verified 2026-04-11

Somnigroup International Inc. Common Stock (SGI) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.

No Form 4 insider filings for SGI were recorded at the SEC in the past 30 days[1].

Sources

  1. SEC EDGAR · 0001206264 (2026-04-11)
Not financial advice. BiotechSigns scores are for informational purposes only and do not constitute investment recommendations. Always do your own due diligence before making investment decisions.
No active signals for SGI
Signal Summary
PDUFA0
Insider0
Clinical0
Data Sources
Dilution◌ LOADING
Sentiment◌ LOADING
SEC EDGAR● LIVE
ClinicalTrials● LIVE
Yahoo Finance● LIVE